ERBB2 and cancer: If less than 10% of the infiltrating cancer cells have intact brown cell membranes or more than 10% of the infiltrating cancer cells have incomplete and/or weak to moderate membranous staining, the case is diagnosed as 2+ (HER2-equivocal) and the further ISH testing is needed to assess HER2 expression [6].